Advanced Solid Malignancies Completed Phase 1 Trials for Sapitinib (DB12183)

Also known as: Advanced Solid Malignancy

IndicationStatusPhase
DBCOND0034803 (Advanced Solid Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00637039Study of AZD8931 in Patients With Advanced Solid MalignanciesTreatment